New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
26th September 2023
28th August 2023
23rd August 2023
16th August 2023
1st August 2023
South Africa: The Portfolio Committee on Health has extended to 4th September the deadline for written comments on the Tobacco Products and Electronic Delivery Systems Control Bill, which aims to regulate the sale, advertising and packaging of tobacco products and e-cigarettes. Comments should be submitted by email to tobaccobill@parliament.gov.za or through an online form.
27th July 2023
South Africa: Tomorrow, 28th July, is the last day to present written submissions on the Tobacco Products and Electronic Delivery System Control Bill. Comments on the bill, which aims to regulate the sale, advertising and packaging of tobacco products and e-cigarettes, should be submitted by email to tobaccobill@parliament.gov.za or through an online form.
12th July 2023
Ghana: The Food and Drugs Authority (FDA) has issued a statement saying the sale, advertising and recreational use of nicotine e-cigarettes and “other non-nicotine tobacco products” are forbidden. It calls on manufacturers, importers, wholesalers and retailers to immediately remove all advertisements for products that can be registered “as a prescription only medicine for smoking cessation”, and to stop importing them.
7th July 2023
3rd July 2023
29th June 2023
22nd June 2023
South Africa: The Portfolio Committee on Health has opened the Tobacco Products and Electronic Delivery Systems Control Bill for written submissions from interested individuals and stakeholders. Comments on the bill, which aims to regulate the sale, advertising and packaging of tobacco products and e-cigarettes, should be submitted by email to tobaccobill@parliament.gov.za or through an online form no later than 4th August.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.